The following report explores a 10-year review of Med-Tech funding trends. As it appears that institutional funding has indeed become much more challenging to secure, it raises many important questions. Among the most pressing are: why it this happening? Are there other options to secure the funding necessary to be commercially successful? Download this report by clicking above.
Healthcare Sector Expertise
The Mirus team has worked with the owners of closely-held companies in multiple segments of the $2.8 trillion US healthcare industry. We benefit from being in the hub of healthcare investing in the US – with one of the most active venture capital communities, global pharmaceutical research centers and leading universities, large medical device companies and innovative med-tech and healthcare services firms.
Healthcare is an active area for M&A and an attractive segment for private equity investing, capturing between 10% and 20% of total global private equity investing each year. The Mirus healthcare team has experience raising capital for growing healthcare businesses and experience in strategic M&A with some of the largest healthcare companies in the industry. We have expertise in all facets of the healthcare market, including:
- Medical devices
- Healthcare equipment
- Healthcare information technology
- Contract research
- Healthcare staffing
Mirus provides direct access to sector-specific expertise, as well as knowledge of, access to and relationships with global buyers and sellers in the healthcare sector.